These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

919 related items for PubMed ID: 31735357

  • 1. Structure elucidation {spectroscopic, single crystal X-ray diffraction and computational DFT studies} of new tailored benzenesulfonamide derived Schiff base copper(II) intercalating complexes: Comprehensive biological profile {DNA binding, pBR322 DNA cleavage, Topo I inhibition and cytotoxic activity}.
    Afsan Z, Roisnel T, Tabassum S, Arjmand F.
    Bioorg Chem; 2020 Jan; 94():103427. PubMed ID: 31735357
    [Abstract] [Full Text] [Related]

  • 2. New modulated design and synthesis of quercetin-Cu(II)/Zn(II)-Sn2(IV) scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity.
    Tabassum S, Zaki M, Afzal M, Arjmand F.
    Dalton Trans; 2013 Jul 21; 42(27):10029-41. PubMed ID: 23715526
    [Abstract] [Full Text] [Related]

  • 3. Copper (II)-based halogen-substituted chromone antitumor drug entities: Studying biomolecular interactions with ct-DNA mediated by sigma hole formation and cytotoxicity activity.
    Arjmand F, Khursheed S, Roisnel T, Siddique HR.
    Bioorg Chem; 2020 Nov 21; 104():104327. PubMed ID: 33142405
    [Abstract] [Full Text] [Related]

  • 4. Surfactant-copper(II) Schiff base complexes: synthesis, structural investigation, DNA interaction, docking studies, and cytotoxic activity.
    Lakshmipraba J, Arunachalam S, Solomon RV, Venuvanalingam P, Riyasdeen A, Dhivya R, Akbarsha MA.
    J Biomol Struct Dyn; 2015 Nov 21; 33(4):877-91. PubMed ID: 24854148
    [Abstract] [Full Text] [Related]

  • 5. Mixed-ligand copper(ii) Schiff base complexes: the role of the co-ligand in DNA binding, DNA cleavage, protein binding and cytotoxicity.
    Lian WJ, Wang XT, Xie CZ, Tian H, Song XQ, Pan HT, Qiao X, Xu JY.
    Dalton Trans; 2016 May 31; 45(22):9073-87. PubMed ID: 27163172
    [Abstract] [Full Text] [Related]

  • 6. Designing, structural elucidation, comparison of DNA binding, cleavage, radical scavenging activity and anticancer activity of copper(I) complex with 5-dimethyl-2-phenyl-4-[(pyridin-2-ylmethylene)-amino]-1,2-dihydro-pyrazol-3-one Schiff base ligand.
    Sathiyaraj S, Sampath K, Butcher RJ, Pallepogu R, Jayabalakrishnan C.
    Eur J Med Chem; 2013 Jun 31; 64():81-9. PubMed ID: 23644191
    [Abstract] [Full Text] [Related]

  • 7. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
    Zhou XQ, Li Y, Zhang DY, Nie Y, Li ZJ, Gu W, Liu X, Tian JL, Yan SP.
    Eur J Med Chem; 2016 May 23; 114():244-56. PubMed ID: 26994692
    [Abstract] [Full Text] [Related]

  • 8. Influence of anchoring moieties on new benzimidazole-based Schiff base copper(II) complexes towards estrogen dependent breast cancer cells.
    Paul A, Singh P, Kuznetsov ML, Karmakar A, Guedes da Silva MFC, Koch B, Pombeiro AJL.
    Dalton Trans; 2021 Mar 16; 50(10):3701-3716. PubMed ID: 33634805
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, spectroscopic and biological activity evaluation of Ni(II), Cu(II) and Zn(II) complexes of schiff base derived from pyridoxal and 4-fluorobenzohydrazide.
    Kavitha R, Reddy CVR, Sireesha B.
    Nucleosides Nucleotides Nucleic Acids; 2021 Mar 16; 40(8):845-866. PubMed ID: 34379029
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and characterization of heterobimetallic SnIV-CuII/ZnII complexes: DFT studies, cleavage potential and cytotoxic activity.
    Afzal M, Usman M, Al-Lohedan HA, Tabassum S.
    J Biomol Struct Dyn; 2020 Mar 16; 38(4):1130-1142. PubMed ID: 30885099
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, crystal structure and antiproliferative activity of Cu(II) nalidixic acid-DACH conjugate: comparative in vitro DNA/RNA binding profile, cleavage activity and molecular docking studies.
    Arjmand F, Yousuf I, Hadda Tb, Toupet L.
    Eur J Med Chem; 2014 Jun 23; 81():76-88. PubMed ID: 24826817
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, DNA binding, cellular DNA lesion and cytotoxicity of a series of new benzimidazole-based Schiff base copper(II) complexes.
    Paul A, Anbu S, Sharma G, Kuznetsov ML, Koch B, Guedes da Silva MF, Pombeiro AJ.
    Dalton Trans; 2015 Dec 14; 44(46):19983-96. PubMed ID: 26523453
    [Abstract] [Full Text] [Related]

  • 13. DNA binding, cleavage and cytotoxicity studies of three mononuclear Cu(II) chloro-complexes containing N-S donor Schiff base ligands.
    Parsekar SU, Fernandes J, Banerjee A, Chouhan OP, Biswas S, Singh M, Mishra DP, Kumar M.
    J Biol Inorg Chem; 2018 Dec 14; 23(8):1331-1349. PubMed ID: 30302601
    [Abstract] [Full Text] [Related]

  • 14. Chiral heterobimetallic complexes targeting human DNA-topoisomerase Iα.
    Tabassum S, Asim A, Khan RA, Hussain Z, Srivastav S, Srikrishna S, Arjmand F.
    Dalton Trans; 2013 Dec 28; 42(48):16749-61. PubMed ID: 24077532
    [Abstract] [Full Text] [Related]

  • 15. RNA-targeted Cu(II)-based potential antitumor drug entity: comprehensive structural, biological {DNA/RNA binding, cleavage, cytotoxicity} and computational studies.
    Parveen S, Fatima K, Zehra S, Arjmand F.
    J Biomol Struct Dyn; 2021 Oct 28; 39(16):6070-6083. PubMed ID: 32715942
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Homo- and heteroleptic trimethoxy terpyridine-Cu(ii) complexes: synthesis, characterization, DNA/BSA binding, DNA cleavage and cytotoxicity studies.
    Jain S, Bhar K, Kumar S, Bandyopadhyaya S, Tapryal S, Mandal CC, Sharma AK.
    Dalton Trans; 2020 Apr 01; 49(13):4100-4113. PubMed ID: 32141470
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.